Our ProductsFor PhysiciansFor LaboratoriesFor PatientsOur Technology
Print This Page | Text Size: A A A

About eXagen DIAGNOSTICS, Inc.™



eXagen DIAGNOSTICS, Inc.™ is a leader in the discovery, development and delivery of genomic marker tests that will assist physicians with disease diagnosis, prognosis and treatment response.

Headquartered in Albuquerque, New Mexico, with offices in Houston, Texas, eXagen DIAGNOSTICS, Inc., or eXagen, is a molecular diagnostics company that is focused on identifying and developing genomic marker sets for diagnostic, prognostic and predictive treatment response tests across a number of disease categories. These disease categories include but are not limited to cancer, digestive disorders, and infectious disease treatment response.

eXagen Discovers: eXagen's proprietary computational engine, Coperna™, can identify gene marker sets in a matter of weeks as opposed to months or years. Coperna allows us to conduct a significant number of computations and to quickly identify small, precise sets of genomic markers that are most meaningful to the diagnosis, prognosis, or treatment response by patients with a given disease. The complexity and power of the Coperna technology is the engine and speed behind our discovery process.

eXagen Develops: eXagen's unique discovery process provides us with the ability to design and develop a limitless number of molecular diagnostic test across a wide range of clinical applications. These applications include disease diagnosis, assessment of disease recurrence and determining a patient's response to treatment before the treatment is rendered.

eXagen Delivers: eXagen is committed to translating our discovery and development into real solutions that are safe, reliable and cost effective.


Mission
eXagen discovers, develops, manufactures and markets genomic marker products to clinical laboratories and pharmaceutical companies on a worldwide basis.

Vision
The medical community, when faced with challenging health care decisions, chooses eXagen's revolutionary genomic-based in vitro diagnostics products and services to improve patient care and quality of life.

Corporate Values
  • Foster trust, participation and ownership
  • Transact business ethically
  • Exhibit a positive attitude during internal and external interactions
  • Provide the highest quality products and support to our customers
  • Innovate in leading-edge medicine, biology and informatics
  • Excel in management and leadership
  • Provide value to our shareholders
  • Be a customer-focused organization